Status:
ACTIVE_NOT_RECRUITING
Topical Statin Eye Drop in the Management of the Dry Eye
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Dry Eye Disease
Eligibility:
All Genders
20+ years
Phase:
PHASE1
PHASE2
Brief Summary
In the first stage, to evaluate the safety of the topical medication produced by Sina Pharmaceuticals, this medication is experimentally tested on 10 volunteer patients. If no side effects occur, elig...
Eligibility Criteria
Inclusion
- Age\>20 years old
- Dry eye induced by Meibomian gland dysfunction
- Tear break up time less than 10 seconds
Exclusion
- Hematologic disorders
- Coagulopathies
- Use of anticoagulant medication
- Use of Peptic ulcer disease
- History of ocular surgeries in the last 3 months
- History of any ocular Malignancies
- History of ocular trauma
- History of statin use
Key Trial Info
Start Date :
January 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06208384
Start Date
January 4 2024
End Date
February 4 2025
Last Update
January 17 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmic Research Center
Tehran, Iran